Talking Medicines Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 39

Employees

  • Latest Deal Type
  • Debt Refin.

  • Latest Deal Amount
  • $365K

  • Investors
  • 5

Talking Medicines General Information

Description

Developer of a healthcare technology tool designed to capture, curate, and structure the voice of the patient on launched medicines. The company's platform uses a collection of artificial intelligence, machine learning, and neuro-linguistic programming technological tools to capture and analyze the conversations and behaviors of patients at home and map the patient voice to regulate medicine information and build data points to deliver trends and patterns of usage across medicines and brands, enabling pharmaceutical companies to identify patterns of data across multiple medicines and their therapeutic areas of interest.

Contact Information

Formerly Known As
Virtual Genie, Purple Pet People
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • BECO Building
  • 58 Kingston Street
  • Glasgow G5 8BP
  • Scotland, United Kingdom
+44 055
Primary Industry
Other Healthcare Technology Systems
Other Industries
Medical Records Systems
Corporate Office
  • BECO Building
  • 58 Kingston Street
  • Glasgow G5 8BP
  • Scotland, United Kingdom
+44 055

Talking Medicines Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Talking Medicines Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Debt Refinancing 26-May-2026 $365K Completed Generating Revenue
9. Debt - General Completed Generating Revenue
8. Debt Refinancing 12-Dec-2025 Completed Generating Revenue
7. Later Stage VC 05-Dec-2023 Completed Generating Revenue
6. Later Stage VC (Series A) 31-Jan-2022 Completed Generating Revenue
5. Later Stage VC 04-Nov-2020 Completed Generating Revenue
4. Seed Round 10-May-2019 Completed Generating Revenue
3. Seed Round 16-Jun-2018 Completed Generating Revenue
2. Seed Round 28-Aug-2017 $171K $171K Completed Generating Revenue
1. Grant $125K Completed Startup
To view Talking Medicines’s complete valuation and funding history, request access »

Talking Medicines Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Series A
Ordinary 61,694 $0.001000 $13.91 $13.91 1x $13.91 16.24%
Ordinary 9,826 $0.001000 $13.43 $13.43 1x $13.43 2.59%
To view Talking Medicines’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Talking Medicines Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a healthcare technology tool designed to capture, curate, and structure the voice of the patient on launche
Other Healthcare Technology Systems
Glasgow, United Kingdom
39 As of 2025

London, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Talking Medicines Competitors (1)

One of Talking Medicines’s competitors is Brandwatch, a Private Equity-Backed company based in London, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Brandwatch Private Equity-Backed London, United Kingdom
You’re viewing 1 of 1 competitors. Get the full list »

Talking Medicines Patents

Talking Medicines Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202316695-D0 Method and apparatus for identifying patterns in interactions with medicines Inactive 31-Oct-2023
WO-2025093878-A1 Method and apparatus for identifying patterns in interactions with medicines Inactive 31-Oct-2023
GB-202101783-D0 Medicine evaluation system Inactive 09-Feb-2021
US-20240120114-A1 Medicine evaluation system Pending 09-Feb-2021
WO-2022171996-A1 Medicine evaluation system Inactive 09-Feb-2021 G06F16/3344
To view Talking Medicines’s complete patent history, request access »

Talking Medicines Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Talking Medicines Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Tern (Private Equity) Venture Capital Minority
Scottish Enterprise Growth/Expansion Minority
SIS Ventures Impact Investing Minority
The Scottish National Investment Bank Investment Bank Minority
To view Talking Medicines’s complete investors history, request access »

Talking Medicines FAQs

  • When was Talking Medicines founded?

    Talking Medicines was founded in 2013.

  • Where is Talking Medicines headquartered?

    Talking Medicines is headquartered in Glasgow, United Kingdom.

  • What is the size of Talking Medicines?

    Talking Medicines has 39 total employees.

  • What industry is Talking Medicines in?

    Talking Medicines’s primary industry is Other Healthcare Technology Systems.

  • Is Talking Medicines a private or public company?

    Talking Medicines is a Private company.

  • What is Talking Medicines’s current revenue?

    The current revenue for Talking Medicines is .

  • How much funding has Talking Medicines raised over time?

    Talking Medicines has raised $6.46M.

  • Who are Talking Medicines’s investors?

    , Tern (Private Equity), Scottish Enterprise, SIS Ventures, and The Scottish National Investment Bank have invested in Talking Medicines.

  • Who are Talking Medicines’s competitors?

    Brandwatch is a competitor of Talking Medicines.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process